Evidence map›Paper›PMID 35071436›Full record

ArticleAnnals of translational medicine2021

Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy.

Xi'e Hu, Zhenyu Yang, Songhao Chen, Jingyi Xue, Sensen Duan, Lin Yang, Ping Yang, Shujia Peng, Yanming Dong, Lijuan Yuan and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Xi'e Hu *Department of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Zhenyu Yang *Department of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Songhao Chen *Department of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Jingyi XueThe Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, China.
Sensen DuanDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Lin YangDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Ping YangDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Shujia PengDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Yanming DongDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Lijuan YuanDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Xianli HeDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Guoqiang BaoDepartment of General Surgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Shaanxi University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer (GC) is one of the most malignant diseases and threatens the health of individuals across the globe. Hitherto, the identification of prognosis risk stratification on GC has mainly depended on the TNM staging, but owing to its inaccuracy and incompleteness, the prognostic value it offers remains controversial in the current clinical setting. Thus, an effective prognostic model for GC after radical gastrectomy is still needed.

methodsPatients with pathologically confirmed GC who underwent radical gastrectomy from 2 different centers were retrospectively enrolled into a training and the validation cohort, respectively. The least absolute shrinkage and selection operator (LASSO) algorithm was applied to select variables among multiple factors, including clinical characteristics, pathological parameters, and surgery- and treatment-related indicators. The multivariate Cox regression method was used to establish the model to predict 1-, 2-, and 3-year survival. Both internal and external validations of the nomogram were then completed in terms of discrimination, calibration, and clinical utility. Finally, prognostic risk stratification of GC was conducted with X-tile software.

resultsA total of 1,424 patients with GC were eligible in this study, including 1,010 in the training cohort and 414 in the validation cohort. Seven indicators were selected by LASSO to develop the nomogram, including the number of positive lymph nodes, tumor size, adjacent organ invasion, vascular invasion, the level of carbohydrate antigen 125 (CA 125), depth of invasion, and human epidermal growth factor receptor 2 (HER2) status. The nomogram demonstrated a robust predictive capacity with favorable accuracy, discrimination, and clinical utility both in the internal and external validations. Moreover, we divided the population into 3 risk groups of survival according to the cutoff points generated by X-tile, and in this way, the nomogram was further improved into a risk-stratified prognosis model.

conclusionsWe have developed a prognostic risk stratification nomogram for GC patients after radical gastrectomy with 7 available indicators that may guide clinical practice and help facilitate tailored decision-making, thus avoiding overtreatment or undertreatment and improving communication between clinicians and patients.

Indexed as

external validationGastric cancer (GC)human epidermal growth factor receptor 2 (HER2)nomogramprognosis

Identifiers

PMID35071436
PMCPMC8743701
OpenAlexW4205622682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.